84 related articles for article (PubMed ID: 18261462)
1. Phosphorylation of Runx1 at Ser249, Ser266, and Ser276 is dispensable for bone marrow hematopoiesis and thymocyte differentiation.
Tachibana M; Tezuka C; Muroi S; Nishimoto S; Katsumoto T; Nakajima A; Kitabayashi I; Taniuchi I
Biochem Biophys Res Commun; 2008 Apr; 368(3):536-42. PubMed ID: 18261462
[TBL] [Abstract][Full Text] [Related]
2. Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis.
Pozner A; Lotem J; Xiao C; Goldenberg D; Brenner O; Negreanu V; Levanon D; Groner Y
BMC Dev Biol; 2007 Jul; 7():84. PubMed ID: 17626615
[TBL] [Abstract][Full Text] [Related]
3. The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells.
Egawa T; Tillman RE; Naoe Y; Taniuchi I; Littman DR
J Exp Med; 2007 Aug; 204(8):1945-57. PubMed ID: 17646406
[TBL] [Abstract][Full Text] [Related]
4. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
Huang G; Zhang P; Hirai H; Elf S; Yan X; Chen Z; Koschmieder S; Okuno Y; Dayaram T; Growney JD; Shivdasani RA; Gilliland DG; Speck NA; Nimer SD; Tenen DG
Nat Genet; 2008 Jan; 40(1):51-60. PubMed ID: 17994017
[TBL] [Abstract][Full Text] [Related]
5. A 5' untranslated region containing the IRES element in the Runx1 gene is required for angiogenesis, hematopoiesis and leukemogenesis in a knock-in mouse model.
Nagamachi A; Htun PW; Ma F; Miyazaki K; Yamasaki N; Kanno M; Inaba T; Honda Z; Okuda T; Oda H; Tsuji K; Honda H
Dev Biol; 2010 Sep; 345(2):226-36. PubMed ID: 20647008
[TBL] [Abstract][Full Text] [Related]
6. RUNX1 DNA-binding mutants, associated with minimally differentiated acute myelogenous leukemia, disrupt myeloid differentiation.
Cammenga J; Niebuhr B; Horn S; Bergholz U; Putz G; Buchholz F; Löhler J; Stocking C
Cancer Res; 2007 Jan; 67(2):537-45. PubMed ID: 17234761
[TBL] [Abstract][Full Text] [Related]
7. Inability of RUNX1/AML1 to breach AML1-ETO block of embryonic stem cell definitive hematopoiesis.
Peterson LF; Lo MC; Okumura AJ; Zhang DE
Blood Cells Mol Dis; 2007; 39(3):321-8. PubMed ID: 17692541
[TBL] [Abstract][Full Text] [Related]
8. Overexpression or knock-down of runt-related transcription factor 1 affects BCR-ABL-induced proliferation and migration in vitro and leukemogenesis in vivo in mice.
Yang LJ; Yu WD; DU JB; Chao S; Chen MX; Zhao HH; Guo JZ
Chin Med J (Engl); 2009 Feb; 122(3):331-7. PubMed ID: 19236814
[TBL] [Abstract][Full Text] [Related]
9. Increase of hematopoietic progenitor and suppression of endothelial gene expression by Runx1 expression during in vitro ES differentiation.
Sakai E; Kitajima K; Sato A; Nakano T
Exp Hematol; 2009 Mar; 37(3):334-45. PubMed ID: 19218012
[TBL] [Abstract][Full Text] [Related]
10. RUNX1 suppression induces megakaryocytic differentiation of UT-7/GM cells.
Nagai R; Matsuura E; Hoshika Y; Nakata E; Nagura H; Watanabe A; Komatsu N; Okada Y; Doi T
Biochem Biophys Res Commun; 2006 Jun; 345(1):78-84. PubMed ID: 16674921
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-27 enhances differentiation of myeloblasts into granulocytes by post-transcriptionally downregulating Runx1.
Feng J; Iwama A; Satake M; Kohu K
Br J Haematol; 2009 May; 145(3):412-23. PubMed ID: 19298589
[TBL] [Abstract][Full Text] [Related]
12. Multiple phosphorylation sites are important for RUNX1 activity in early hematopoiesis and T-cell differentiation.
Yoshimi M; Goyama S; Kawazu M; Nakagawa M; Ichikawa M; Imai Y; Kumano K; Asai T; Mulloy JC; Kraft AS; Takahashi T; Shirafuji N; Kurokawa M
Eur J Immunol; 2012 Apr; 42(4):1044-50. PubMed ID: 22531928
[TBL] [Abstract][Full Text] [Related]
13. LPXN, a member of the paxillin superfamily, is fused to RUNX1 in an acute myeloid leukemia patient with a t(11;21)(q12;q22) translocation.
Dai HP; Xue YQ; Zhou JW; Li AP; Wu YF; Pan JL; Wang Y; Zhang J
Genes Chromosomes Cancer; 2009 Dec; 48(12):1027-36. PubMed ID: 19760607
[TBL] [Abstract][Full Text] [Related]
14. Dynamic expression of Runx1 in skin affects hair structure.
Raveh E; Cohen S; Levanon D; Negreanu V; Groner Y; Gat U
Mech Dev; 2006 Nov; 123(11):842-50. PubMed ID: 17011173
[TBL] [Abstract][Full Text] [Related]
15. Runx1 promotes B-cell survival and lymphoma development.
Blyth K; Slater N; Hanlon L; Bell M; Mackay N; Stewart M; Neil JC; Cameron ER
Blood Cells Mol Dis; 2009; 43(1):12-9. PubMed ID: 19269865
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
17. Runx1 modulates developmental, but not injury-driven, hair follicle stem cell activation.
Osorio KM; Lee SE; McDermitt DJ; Waghmare SK; Zhang YV; Woo HN; Tumbar T
Development; 2008 Mar; 135(6):1059-68. PubMed ID: 18256199
[TBL] [Abstract][Full Text] [Related]
18. Loss of RUNX1/AML1 arginine-methylation impairs peripheral T cell homeostasis.
Mizutani S; Yoshida T; Zhao X; Nimer SD; Taniwaki M; Okuda T
Br J Haematol; 2015 Sep; 170(6):859-73. PubMed ID: 26010396
[TBL] [Abstract][Full Text] [Related]
19. Unique N-terminal sequences in two Runx1 isoforms are dispensable for Runx1 function.
Nieke S; Yasmin N; Kakugawa K; Yokomizo T; Muroi S; Taniuchi I
BMC Dev Biol; 2017 Oct; 17(1):14. PubMed ID: 29047338
[TBL] [Abstract][Full Text] [Related]
20. [Transcription factor RUNX1].
Markova EN; Petrova NV; Razin SV; Kantidze OL
Mol Biol (Mosk); 2012; 46(6):846-59. PubMed ID: 23350231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
